Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Y Tsai

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Archives of Dermatology|June 20, 2007
Systemic adjuvant therapy for patients with high-risk melanomaKenneth Y Tsai
Archives of Dermatology|May 18, 2011
Assessing the treatment of nonmelanoma skin cancersKenneth Y Tsai
Seminars in Cutaneous Medicine and Surgery|August 3, 2014
Precision medicineKenneth Y Tsai
The Journal of Investigative Dermatology|December 20, 2021
The Origins of Merkel Cell Carcinoma: Defining Paths to the Neuroendocrine PhenotypeKenneth Y Tsai
Archives of Dermatology|June 22, 2005
Evidence-based medicine: do we use guidelines or mindlines? Commentary on: Evidence-based guidelines or collectively constructed "mindlines?" ethnographic study of knowledge management in primary care. Gabbay J, le May G BMJ. 2004;329:1013Kenneth Y Tsai
Archives of Dermatology|November 23, 2005
A potential pathogenic role for aberrant DNA rearrangements in bridging dyscrasias of undetermined significance and lymphoma?Kenneth Y Tsai
Molecular Carcinogenesis|May 23, 2019
Molecular and immune targets for Merkel cell carcinoma therapy and preventionLeah Cohen, Kenneth Y Tsai
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 7, 2004
The genetics of skin cancerKenneth Y Tsai, Hensin Tsao
Journal of the American Academy of Dermatology|April 18, 2007
Primer on the human genomeKenneth Y Tsai, Hensin Tsao
Molecular Carcinogenesis|August 24, 2022
Molecular and immune targets in cutaneous squamous cell carcinomaJustine Galambus, Kenneth Y Tsai
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Archives of Dermatology|June 20, 2007
Systemic adjuvant therapy for patients with high-risk melanomaKenneth Y Tsai
Archives of Dermatology|May 18, 2011
Assessing the treatment of nonmelanoma skin cancersKenneth Y Tsai
Seminars in Cutaneous Medicine and Surgery|August 3, 2014
Precision medicineKenneth Y Tsai
The Journal of Investigative Dermatology|December 20, 2021
The Origins of Merkel Cell Carcinoma: Defining Paths to the Neuroendocrine PhenotypeKenneth Y Tsai
Archives of Dermatology|June 22, 2005
Evidence-based medicine: do we use guidelines or mindlines? Commentary on: Evidence-based guidelines or collectively constructed "mindlines?" ethnographic study of knowledge management in primary care. Gabbay J, le May G BMJ. 2004;329:1013Kenneth Y Tsai
Archives of Dermatology|November 23, 2005
A potential pathogenic role for aberrant DNA rearrangements in bridging dyscrasias of undetermined significance and lymphoma?Kenneth Y Tsai
Molecular Carcinogenesis|May 23, 2019
Molecular and immune targets for Merkel cell carcinoma therapy and preventionLeah Cohen, Kenneth Y Tsai
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 7, 2004
The genetics of skin cancerKenneth Y Tsai, Hensin Tsao
Journal of the American Academy of Dermatology|April 18, 2007
Primer on the human genomeKenneth Y Tsai, Hensin Tsao
Molecular Carcinogenesis|August 24, 2022
Molecular and immune targets in cutaneous squamous cell carcinomaJustine Galambus, Kenneth Y Tsai
Pageof 13